Format

Send to

Choose Destination
World J Gastroenterol. 2011 Aug 7;17(29):3420-30. doi: 10.3748/wjg.v17.i29.3420.

Late SV40 factor: a key mediator of Notch signaling in human hepatocarcinogenesis.

Author information

1
Department of Pathology, School of Medicine, Southeast University, Nanjing 210009, Jiangsu Province, China.

Abstract

AIM:

To investigate the relationship between late SV40 factor (LSF) and Notch signaling in the development and progress of hepatocellular carcinoma (HCC).

METHODS:

Liver cancer tissue specimens from 25 patients were analyzed for Notch-1 and LSF expression by immunohistochemistry. The correlation between expression and the biological effects of Notch-1 and LSF were analyzed using genetic and pharmacological strategies in HCC cell lines and human normal cell lines, including hepatic stellate cells (HSC) and human embryonic kidney epithelial cells (HEK).

RESULTS:

Immunohistochemistry showed that both Notch-1 and LSF were significantly upregulated in HCC samples (76%, 19/25, P < 0.0001 and 84%, 21/25, P < 0.0001, respectively) compared with non-cancer samples. Activation of Notch-1 by exogenous transfection of Notch1 intracellular domain increased LSF expression in HSC and HEK cells to levels similar to those seen in HepG2 cells. Furthermore, blocking Notch-1 activation with a γ-secretase inhibitor, DAPT, downregulated LSF expression in HepG2 cells. Additionally, a biological behavior assay showed that forced overexpression of LSF promoted HepG2 cell proliferation and invasion.

CONCLUSION:

LSF is a key mediator of the Notch signaling pathway, suggesting that it might be a novel therapeutic target for the treatment of HCC.

KEYWORDS:

Hepatocellular carcinoma; Late SV40 factor; Notch receptor; Signal transduction

PMID:
21876634
PMCID:
PMC3160568
DOI:
10.3748/wjg.v17.i29.3420
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Baishideng Publishing Group Inc. Icon for PubMed Central
Loading ...
Support Center